- Reshaping Advanced or Metastatic Breast Cancer: Antibody-Drug Conjugates (ADC)
- Adjuvant Therapies for Early-Stage Breast Cancer
- Real World Oncology: Translating Data to Clinical Practice
- Optimizing Treatment Selection in 1L Metastatic Setting with a focus on CDK4/6 inhibitors
- Post-Frontline CDK4/6: How do you sequence in Advanced/Metastatic Breast Cancer?
- Real World Oncology: Translating Data to Clinical Practice
- Live Q&A
OncLive® State of the Science Summit™ Breast Cancer
Glasshouse Chelsea
545 W 25th St 14th floor
New York, NY 10001
United States
Thursday, January 22, 2026
6:00 PM-9:00 PM ET
Complimentary Parking
In-Person Only
Event Chair
Komal Jhaveri, MD, FACP, FASCO
Memorial Sloan Kettering Cancer Center
IN PARTNERSHIP WITH.png)
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512